comparemela.com

Latest Breaking News On - பட்டியலிடப்பட்டுள்ளது - Page 8 : comparemela.com

Revenue on the rise for listed dealer group

Revenue on the rise for listed dealer group Revenue on the rise for listed dealer group The listed advice group recorded a 15 per cent increase in gross revenue for the first half of the 2021 year, lifting its profits significantly as advice revenue rose. A A In a statement to the market on Friday, Centrepoint Alliance said it had recorded gross revenue of $70.6 million for the six months to December 2020, up 15 per cent on the prior corresponding period. The group said its net profit after tax for the first half of the 2021 financial year was $1.6 million, compared with a loss of $1.5 million for the same period last year.

Invesco Trust for Investment Grade New York Municipals : Closed-End Funds Declare Dividends

Sankyo : Notice concerning Dissolution and Liquidation of a Consolidated Subsidiary

Singapore bank UOB eyes lower credit costs, Q4 profit falls 32%

Kanabo Group Plc: Newly Listed on LSE, Kanabo Group Announces Partnership With the UK s Biggest Cannabis Clinic Provider, LYPHE Group

(2) Kanabo Group Plc, a medical cannabis company that recently debuted on London Stock Exchange, is delighted to announce it has signed its first UK medicinal cannabis distribution framework agreement with Astral Health Limited ( Astral Health ). Astral Health is fully owned by LYPHE Group, which is part of Drug Science s Project Twenty21. According to the agreement, Kanabo will supply its medical-grade inhalation device, VapePod and a line of medicinal cannabis formulations in pods for the UK market. Through this new framework agreement, it is intended that Kanabo s VapePod medicinal cannabis formula, under brand NOIDECS will be made available to Project Twenty21 patients. Project Twenty21 provides eligible patients with affordable medical cannabis treatment, monitored by Drug Science. The project aims to create the UK s largest body of evidence for the effectiveness and tolerability of medical cannabis.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.